DRG International Exhibiting at ASH Annual Meeting 2018 – Booth #3009
DRG International, Inc. is proud to be a featured participant at ASH 2018, held in San Diego, CA from December 1 – 4, 2018! Please visit the DRG booth at #3009 to learn more about our products, including our Hepcidin 25-bioactive HS ELISA Kit. NEW Hepcidin 25...
read more
DRG has launched 2 NEW ELISA Kits: Free T3 ELISA and Free T4 ELISA
DRG is proud to announce 2 NEW ELISA kits: Free T3 ELISA and Free T4 ELISA, EIA-3801 / EIA-3775! The NEW ELISAs are robust, high quality, and have good correlation to Roche assays. Please see the most important features listed below: Reagents ready to...
read more
Visit DRG at MEDICA 2018! Hall 3 / Stand A69
DRG International Products on Display at MEDICA 2018 (Booth 3/A69) DRG International is proud to be a featured participant at MEDICA 2018, held in Dusseldorf from November 12 to November 15th. DRG will be one of hundreds of exhibitors at the largest medical congress...
read more
DRG has launched New Diabetes Kits: Ultra Sensitive Insulin and C-Peptide!
Ultrasensitive Insulin (human) ELISA RUO (EIA-6055R) Ultrasensitive C-Peptide (human) ELISA RUO (EIA-6056R) These two ultrasensitive assays are for testing when a measurement of an extra sensitive and specific quantitative determination of a sample is...
read more
Salivary Hepcidin ELISA: Metabolites as Biomarkers for Disease
Salivary Hepcidin ELISA: Metabolites as Biomarkers for Disease Published In: Metabolomics Research - Special Feature of Select Science® Analysis of metabolites found in saliva is a favorable diagnostic solution, as it can be obtained by methods sample...
read more
DRG Attends AACC 2018 in Chicago!
DRG® International, Inc. Recently Showcased Newly Optimized Salivary Kits at AACC 2018! DRG International, a leading international medical diagnostic company, showcased our Newly Optimized DRG® Saliva ELISA Assays at the 2018 AACC in Chicago, IL from July 30 -...
read more
DRG Attends ASM 2018 in Atlanta!
*Image: From L to R: Dr. Alain Rambach, CHROMagar, Ms Christine Civitano, DRG; Mr. Simon Mrad, CHROMagar, Mr. Daniel Williamson, DRG; Mr. Alberto Lerner, CHROMagar. DRG International, Inc., the authorized distributor for CHROMagar, attended the 2018 ASM Microbe...
read more
NEW AMH (Anti-Mullerian Hormone) ELISA Available at DRG!
DRG is proud to announce a new AMH ELISA (EIA-6053), a quantitative and sensitive ELISA for the measurement of Anti Müllerian Hormone. AMH Assay Characteristics EIA-6053 Assay Principle: Sandwich ELISA Dynamic Range: 0.02 - 20 ng/mL Total Assay Time:...
read more
DRG SUCCESSFULLY EXHIBITS AT MEDLAB DUBAI 2018!
The DRG Group recently exhibited at the largest healthcare exhibition & congress in the Middle East: MEDLAB DUBAI from February 5 - 8, 2018 with great success! In addition to the presentation of several new assays DRG offered live demonstrations of...
read more
DRG distributor “SERION-BRAZIL” successfully attends Brazilian Laboratory Medicine Exhibition in Sao Paulo, Brazil
DRG is proud to announce the new partnership with Serion-Brazil and looks forward to a longstanding and successful business relationship! Mr. Gustavo Ruales, DRG International's Latin American Sales Manager, also attended the exhibition to support...
read moreUpcoming Events
Actual problems of modern laboratory medicine. Exhibition "Clinical Laboratory -2019"
Kazan, Russia
Diagnostic 2019 / Modern Laboratory Medicine: Innovative Laboratory Analysis Technologies and their New Clinical Applications
Elista, Russia
Sign Up for Our Newsletter
Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.
Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.